Recombinant Human EBF1 Protein，Strep & His

EBF1 (Early B-Cell Factor 1) is a critical transcription factor involved in B-cell development and differentiation. Its role extends beyond hematopoiesis, influencing various cellular processes, including the regulation of gene expression during immune responses. Recent studies have highlighted the significance of EBF1 as a key player in the transcriptional program of B lineage cells, where it orchestrates the expression of genes necessary for B-cell maturation and function. Research has shown that EBF1 interacts with other transcription factors and co-factors, forming complexes that modulate target gene transcription, which is vital for maintaining B-cell identity. Additionally, EBF1 has been implicated in B-cell malignancies, such as acute lymphoblastic leukemia and lymphoma, marking it as an important biomarker and potential therapeutic target. The production of recombinant EBF1 protein facilitates the detailed study of its structure-function relationships, enabling researchers to dissect its mechanistic role in transcriptional regulation and cellular signaling pathways. Furthermore, understanding the phosphorylation and post-translational modifications of EBF1 can provide insights into its regulatory mechanisms in health and disease. The ongoing research on EBF1 recombinantly expressed proteins aims to elucidate these complex interactions, advancing our knowledge of B-cell biology and potential interventions in immunological disorders and cancers.